Literature DB >> 20036733

Photoinflammatory responses to UV-irradiated ketoprofen mediated by the induction of ROS generation, enhancement of cyclooxygenase-2 expression, and regulation of multiple signaling pathways.

Shicheng Liu1, Hideo Mizu, Hitoshi Yamauchi.   

Abstract

Ketoprofen (KP) is photolabile and undergoes degradation when irradiated by sunlight, causing the development of various skin diseases. In this study, we found that UVB-irradiated KP can lead to inflammatory responses mediated by the induction of COX-2 and production of PGE(2). The ability of cells to repair UVB-induced cyclobutane pyrimidine dimers was impaired by UVB-irradiated KP, which consequently facilitated UVB-induced DNA damage to keratinocytes. The reactive oxygen species (ROS) generated by the photodegradation of KP facilitate UVB-induced inflammation and apoptosis in HaCaT cells. Elevation of the COX-2 levels was inhibited by an NADPH oxidase inhibitor and an NF-kappaB inhibitor but was largely enhanced after glutathione depletion by buthionine sulfoximine. Inhibition of ERK1/2, p38, and PI3K signaling attenuated the induction of COX-2, whereas inhibition of JNK signaling by SP600125 had very little effect. UVB-irradiated KP provoked an appreciable accumulation of pSer(15)-p53/COX-2 complexes, but this nuclear association of complexes was partially inhibited by PD98059. Silencing of COX-2 with siRNA was associated with reduced p53 phosphorylation and enhanced KP-photoinduced loss of mitochondrial membrane potential and cleavage of caspase 3 and PARP. This induction of apoptosis was prevented by N-acetylcysteine. In conclusion, this study highlights the particular inflammatory response to a photooxidative drug and suggests that KP-photoinduced inflammatory responses are predominantly attributable to induction of ROS generation and directly impair DNA repair. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036733     DOI: 10.1016/j.freeradbiomed.2009.12.014

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Protective effect of Schizandrin B against damage of UVB irradiated skin cells depend on inhibition of inflammatory pathways.

Authors:  Chenguang Gao; Hong Chen; Cong Niu; Jie Hu; Bo Cao
Journal:  Bioengineered       Date:  2016-09-30       Impact factor: 3.269

2.  FRA-1 suppresses apoptosis of Helicobacter pylori infected MGC-803 cells.

Authors:  Yang Yang; Benshuai You; Surong Dong; Chenglin Zhou
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

3.  Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases.

Authors:  Wei-Ning Lin; Chih-Chung Lin; Hsin-Yi Cheng; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Protective effects of a new phloretin derivative against UVB-induced damage in skin cell model and human volunteers.

Authors:  Seoungwoo Shin; Hyunwoo Kum; Dehun Ryu; Minkyung Kim; Eunsun Jung; Deokhoon Park
Journal:  Int J Mol Sci       Date:  2014-10-20       Impact factor: 5.923

5.  Attenuation of UV-B exposure-induced inflammation by abalone hypobranchial gland and gill extracts.

Authors:  Chitraporn Kuanpradit; Yamaratee Jaisin; Sumon Jungudomjaroen; Shahida Akter Mitu; Srisombat Puttikamonkul; Prasert Sobhon; Scott F Cummins
Journal:  Int J Mol Med       Date:  2017-03-29       Impact factor: 4.101

6.  Asiaticoside delays senescence and attenuate generation of ROS in UV‑exposure cells through regulates TGF‑β1/Smad pathway.

Authors:  Honghao Jiang; Xiaoyong Zhou; Liuqing Chen
Journal:  Exp Ther Med       Date:  2022-09-08       Impact factor: 2.751

Review 7.  Contact Dermatitis: Classifications and Management.

Authors:  Yan Li; Linfeng Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-15       Impact factor: 8.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.